logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Mesothelioma Malignant

    FiltersReset Filters
    7 results

    • axtle

      (pemetrexed)
      Avyxa Pharma, LLC
      Usage: AXTLE is indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with cisplatin, maintenance therapy after prior chemotherapy, and for recurrent NSCLC. It also treats unresectable malignant pleural mesothelioma in combination with cisplatin. Not for squamous NSCLC.

    • pemetrexed

      (PEMETREXED DISODIUM)
      Fresenius Kabi USA, LLC
      Usage: Pemetrexed for injection is indicated for the treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy, as maintenance therapy, and for recurrent cases. Additionally, it is used with cisplatin for unresectable malignant pleural mesothelioma. Not for squamous cell NSCLC.

    • pemetrexed

      (Pemetrexed disodium)
      NorthStar RxLLC
      Usage: Pemetrexed for Injection is indicated for the treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy, for maintenance therapy, and for recurrent NSCLC post-chemotherapy. It is also indicated for malignant pleural mesothelioma in combination with cisplatin. Not for squamous cell NSCLC.

    • pemetrexed

      (Pemetrexed)
      Solco Healthcare US, LLC
      Usage: Pemetrexed is indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy or as a maintenance treatment. It is also used with cisplatin for malignant pleural mesothelioma in patients who cannot undergo surgery. Not indicated for squamous cell NSCLC.

    • pemetrexed

      (Pemetrexed)
      Teva Pharmaceuticals Inc
      Usage: Pemetrexed Injection is indicated for the treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) in combination with pembrolizumab or cisplatin, and for maintenance or recurrent NSCLC. It is also used with cisplatin for unresectable malignant pleural mesothelioma. Not indicated for squamous NSCLC.

    • pemetrexed dipotassium

      (pemetrexed dipotassium)
      Avyxa Pharma, LLC
      Usage: Pemetrexed for Injection is indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with cisplatin, as maintenance therapy, or for recurrent NSCLC. It is also indicated with cisplatin for malignant pleural mesothelioma when the disease is unresectable or surgery is not an option.

    • pemetrexed disodium

      (Pemetrexed)
      Amneal Pharmaceuticals LLC
      Usage: Pemetrexed for injection is indicated for the initial treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy or as a maintenance therapy post-chemotherapy. It is also indicated, with cisplatin, for treating unresectable malignant pleural mesothelioma. Not for use in squamous cell NSCLC.